EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

A STUDY ON POST-COVID ALLERGIC AIRWAY DISEASE

Dr. Nuzhath Irfana*, Dr. Syed Mohammed Kazim, Dr. M. A. Aleem, Maseera Amtul Mateen and Asma Afreen

ABSTRACT

Aim: To research the onset or progression of post-covid allergic airway illness in a tertiary care facility. Method: To gain a better knowledge of the condition, 90 patients were included in the research, including inpatients and outpatients diagnosed with post-COVID allergic airway disease. It was done to collect patient data. Every piece of information necessary for the study was gathered at the time of enrollment. After putting the data into a Microsoft Excel sheet, it was analyzed, and frequency tables were created using an appropriate statistical analysis technique. The references for this study were found via searches for similar articles, which were done in a hospital where patients were receiving care. Results: Post-covid allergic airway illness, or worsening or development of upper airway allergies, as shown by our study's findings. Among the 90 instances, the average age of individuals impacted was between 30 and 40 years old, with men being more at risk. Symptoms were used to divide the patients into groups. 21% of patients had a cough, 19% had a cough and sob, 18and % had cough and throat discomfort. According to our research, 54(60%) patients developed the symptoms after COVID, and 36(40%) patients had worsening symptoms after COVID. We learned that in (17) 26% of cases patients having hypertension was the most prevalent comorbid condition, Diabetes is the next condition in (15) 23%, asthma in (10) 15% of patients, and allergic rhinosinusitis in (4) 6% and COPD, ILD (1) 2%. Conclusion: Men were more vulnerable than women which could result from increased exposure to pollution and allergens. All 90 patients' primary complaints were taken into account, and among them, the cough was reported by 21% of patients, A total of 19% of patients arrived with cough and SOB, and 18% of the population with cough and throat discomfort. When medication history was taken into account, it was shown that the majority of individuals have hypertension, followed by diabetes mellitus and asthma.

Keywords: .


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 May 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: MAY ISSUE PUBLISHED

    MAY 2024 issue has been successfully launched on MAY 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia